Skip to main content
PureTech Health plc logo

PureTech Health plc — Investor Relations & Filings

Ticker · PRTC ISIN · GB00BPVG5C82 LEI · 213800LVPDNO2Z9T9I39 IL Manufacturing
Open in API
Filings indexed 1,319 across all filing types
Latest filing 2023-06-13 AGM Information
Country GB United Kingdom
Listing IL PRTC

About PureTech Health plc

https://puretechhealth.com/

PureTech Health is a clinical-stage biotherapeutics company dedicated to discovering, developing, and commercializing new classes of medicine for devastating diseases. The company's research and development engine focuses on advancing novel treatments by enhancing on-target efficacy, improving tolerability, or enabling oral administration of therapeutics with validated mechanisms. Its pipeline includes wholly-owned therapeutic candidates targeting a range of conditions, including idiopathic pulmonary fibrosis, neuropsychiatric disorders, and various cancers.

Recent filings

Filing Released Lang Actions
Result of AGM
AGM Information Classification · 99% confidence The document explicitly states it contains the "Results of Annual General Meeting" and details the outcome of every resolution voted upon at the AGM held on June 13, 2023. This directly corresponds to the definition of AGM Information (AGM-R). Although it mentions the Annual Report and Accounts (Resolution 001), the primary purpose and content of this specific filing is the reporting of the voting results, making AGM-R the most accurate classification.
2023-06-13 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is an RNS announcement (RNS Number : 4642C) from PureTech Health PLC, dated June 13, 2023. The title explicitly states 'Transaction in Own Shares' and the content details the purchase of ordinary shares as part of a 'Share Buyback Programme'. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS), which covers the company buying back or selling its own shares (share repurchase/issuance). The document is not a general regulatory filing (RNS) or a report publication announcement (RPA) because it contains the substantive details of the transaction, not just an announcement that a report is available.
2023-06-13 English
6-K
Audit Report / Information Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, PureTech Health plc, with the SEC. It includes a cover letter to shareholders and a letter from KPMG to shareholders. The presence of a letter from KPMG, a well-known audit firm, suggests this is an audit-related communication. The document is relatively short (1629 characters) and does not contain full financial statements or detailed financial analysis. It is not an annual report or interim report but rather an audit report or information related to audit findings or confirmations. Therefore, the most appropriate classification is Audit Report / Information (AR).
2023-06-12 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is an RNS announcement from PureTech Health PLC, dated June 12, 2023. The title explicitly states 'Transaction in Own Shares' and details the purchase of ordinary shares as part of a 'Share Buyback Programme'. This directly corresponds to the definition of a company buying back or selling its own shares. Therefore, the appropriate filing type code is POS (Transaction in Own Shares).
2023-06-12 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states its purpose in the title section: 'Transaction in Own Shares' and references a 'Share Buyback Programme'. It details the date of purchase (8 June 2023), the number of shares purchased (48,064), and the prices paid. This content directly corresponds to the definition of 'Transaction in Own Shares' (share repurchase/issuance). Therefore, the correct filing type code is POS.
2023-06-09 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states the subject is 'Transaction in Own Shares' and details the purchase of ordinary shares as part of a 'Share Buyback Programme'. It provides specific transaction dates, volumes, and prices. This directly corresponds to the definition of 'Transaction in Own Shares', which maps to the filing type code POS (Report of the company buying back or selling its own shares (share repurchase/issuance)). The document is a formal announcement (RNS Number: 0134C) detailing the execution of a buyback, not just an announcement of a future report.
2023-06-08 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.